Across TCGA pan-cancer cohorts, LINC01832 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01832’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01832 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01832 is over-expressed in tumor.

KIRC, LIHC, and CHOL are the cancer types where LINC01832 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01832 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	+0.265	<.001	11	view →
LIHC	All	All	+0.087	.001	2	view →
CHOL	Female	All	+0.326	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC01832 RNA expression & survival · all LINC01832 data types